Clinical Observation of Endoscopic Submucosal Dissection for Early Gastrointestinal Malignant Tumor

HAN Longcai,LIU Yuanting,ZHAO Hui
2013-01-01
Abstract:Objective To study the clinical effect of endoscopic submucosal dissection(ESD) for early gastrointestinal malignant tumor.Methods 73 patients diagnosed of malignant tumor with focus limited to mucosa and submucosa through endoscopy were selected,including 11 gastric cancer patients,37 colon cancer patients and 25 rectal cancer patients.All the 73 patients were treated with endoscopic submucosal dissection(ESD).After operation,the clinical effect was observed in 1-year follow-up.Additionally,gastric cancer,colon cancer and rectal cancer patients of the same number were selected for endoscopic mucosal resection(EMR).Results ESD: 1-time complete dissection 63 cases(86.3%);pathologic curative dissection 60 cases(82.2%),possible curative dissection 8 cases(11.0%),non-curative excision 5 cases(6.8%);complications: bleeding 2 cases(2.7%),perforation 1 case(1.4%),transferred to surgery.Within 1 year's follow-up visit,there was no relapse.EMR: 1time complete dissection 33 cases(45.2%);pathologic curative dissection 29 cases(39.7%),possible curative dissection 21 cases(28.8%),non-curative excision 23 cases(31.5%);complications: bleeding 12 cases(16.4%),perforation 5 cases(6.8%),transferred to surgery.Within 1 year's follow-up,there were 12 cases of relapse.ESD was superior to EMR in both efficacy and prognosis,the difference was statistical significant(P < 0.05).Conclusion ESD for early gastrointestinal malignant tumor is effective,with less complications and good postoperative recovery,it can be used as the common treatment method clinically.
What problem does this paper attempt to address?